
Pharmaceutical Open Innovation Test Bed for Enabling Nano-pharmaceutical Innovative Products An @EU_H2020 funded project under GA no. 953110 🇪🇺
Joined April 2021
- Tweets178
- Following118
- Followers108
- Likes233
PHOENIX OITB retweeted
2023 #nanomedicine highlight:
BNN supported the highly successful Nano2Clinic Stakeholder Workshop: Synergies for Clinical Translation of Nanotechnology in Cancer Therapies in Zagreb (Croatia), hosted by BioNanoNet member IMI.
@phoenixoitb @MyBiotechGmbH
PHOENIX OITB retweeted
Jesús M. de la Fuente, científico del @CSIC, figura en la lista del 2% de los mejores científicos del mundo, de acuerdo a lo publicado por #Elsevier en "Updated science-wide author databases of standardized citation indicators"
➡️elsevier.digitalcommonsdata.…
PHOENIX OITB retweeted
#AAPS #PharmSci360 has been exhilarating so far. Over the past few days, we've had the privilege of engaging with some of our industry's brightest minds and most innovative leaders.
#pharmaceuticalmanufacturing #drugdelivery #pharmaceuticals #pharma #research
PHOENIX OITB retweeted
📅 It’s Micro-, Small and Medium-sized Enterprises Day!
#MSMEs play a crucial role in driving economic growth and sustainable development.
Discover #HaDEA-managed projects supporting them 👉 hadea.ec.europa.eu/news/micr…
#MSMEday #MSMEsDay
PHOENIX OITB retweeted
Join us at the #SafeNMedTech webinar on "Nano-Enabled Medical Tech: From Idea to Market", supported by #ETPN, of prime interest for the #nanomedicine community. July 5, 11am-12:30pm CEST. Free registration 👉 etp-nanomedicine.eu/event/sa…. #innovation #medtech #healthtech #Europe #SME
PHOENIX OITB retweeted
Dear COSTers,
the program and the presentations offered at our CA17140 Stakeholder event held in Zagreb on March 3, 2023 are available on our deedicated website page at:
nano2clinic.eu/stakeholder-o…
PHOENIX OITB retweeted
We're delighted to announce one extra session on Day 2 (March 28) to accompany even more speakers and companies. Looking forward to seeing you in Washington, D.C.
It's not too late to get your ticket: rcpe.at/rcpe-goes-to-washing…
#pharmaceuticalmanufacturing #pharmaceuticals #pharma
PHOENIX OITB retweeted
Today we had a great business lunch with our member Human.technology Styria, where we introduced our projects @H2020_PRIME, @phoenixoitb and @NGMicrofluidics over delicious Syrian food from our neighborhood. 🧆💡
#lifesciences #networking
PHOENIX OITB retweeted
Our jointed Nano2Clinic and Phoenix project stakeholder meeting in Zagreb (HR) has started and is on air. Follow the meeting on: us06web.zoom.us/j/8901554377…
PHOENIX OITB retweeted
Proud to count on @Nanbiosis with this expertise led by Nora Ventosa (@ICMAB-@CIBERBBN) on #clinicaltranslation
@smart4fabry - @phoenixoitb - #NABIHEAL
Make a good use of it! apply by 28 Feb for funded services in #nanopharmaceutical development
phoenix-oitb.eu/open-call/
#ICTSNews
Replying to @icmabCSIC
You can connect online to follow the #ICMABseminar by Elisabet González @NanomolGroup @CIBERBBN @Nanbiosis on #nanopharmaceuticals: from the lab to the market. #techtransfer
PHOENIX OITB retweeted
🆕📢1st competitive OPEN CALL to @NANBIOSIS #ICTS “Cutting-Edge Biomedical Solutions” and services. #CEBiomedS
@CIBERBBN, @ccmijesususon, @_ibima
🗓️ during the whole month of February 2023!
👉bit.ly/OpenCallNANBIOSIS👈
🌟Submit your Access Request!
#nanbiosisexpertise #ICTSNews
PHOENIX OITB retweeted
Dear COSTers,
we invite you to attend the Stakeholder one-day event Nano to Clinic – Synergies for Clinical Translation of Nanotechnology in Cancer Therapies organized by CA17240 and the Phoenix project on March 3, 2023, in Zagreb (Croatia).
All info at nano2clinic.eu/news/stakehol…
PHOENIX OITB retweeted
We're delighted to present our research and its impact in a webinar hosted by Nanomedicine-Austria on November 28 // 11:00 -12:30 CET.
Registration: ow.ly/EXk250LxnzQ
#nano #pharmaceuticalmanufacturing #processdesign #nanomedicine
PHOENIX OITB retweeted
Feeling curious about the presentation “Infrared & Raman Spectroscopy for PAT applications“ given by Paul Gattinger from RECENDT? If you don't want to miss it, mark the 28 November (11:00 - 12:30 CET) in your calendar 🗓️.
Registration here ℹ️ register.gotowebinar.com/reg…
#webinar
PHOENIX OITB retweeted
BNN is in the gift-giving spirit! 🎁 Subscribe to BNN Quarterly by 12 December 2022 and you will be entered into a FREE conference registration raffle at BioNanoMed or NanoSafe in 2023.🎫 The winner will be drawn at random on 13 December.
🫵Subscribe now: mailchi.mp/986d2c1e28e1/bnn-…
PHOENIX OITB retweeted
Looking forward to the #presentation “Digital process design for nanoparticle manufacturing“ by Hannes BAUER from @RCPE at our NanoMedicine-Austria Webinar!
🗓️ 28 November 2022, 11:00 – 12:30 CEST
Register now: register.gotowebinar.com/reg…
#webinar #nanomedicine #NMAT #DontMissOut
PHOENIX OITB retweeted
Interested in nano-pharmaceutical innovation?
Looking for ways to improve your production of nano-pharmaceutical products?🧬
📆 Join us at the #NanoMedicine-Austria webinar on 28 Nov 2022, which will focus on @phoenixoitb!
ℹ️ nanomedicine-austria.at/even…
#scicomm #webinar #nano
PHOENIX OITB retweeted
The first face-to-face @phoenixoitb project meeting takes place this week in LIST facilities in Luxembourg.
"Good manufacturing practice #GMP in nano-pharmaceutical production is the key step to successfully transfer the products from bench to bedside"
phoenix-oitb.eu
PHOENIX OITB retweeted
THIS WEDNESDAY!
Don't miss our #webinar on promoting your research and EU projects on social media. We'll be looking at simple ways to use LinkedIn and Twitter effectively. Great for beginners and casual users!
Get join link➡️bnn.at/events/social-media-w…
#H2020 #HorizonEurope
PHOENIX OITB retweeted
Really interesting talk by Mariana köber @nanomoltech @icmabCSIC @CIBERBBN on "#Quatsomes - versatile #nanovesicles 4 biomedical applications" explaining their patented technology #DELOS scale up under #GMP in @phoenixoitb. With #nanbiosisexpertise of @nanbiosis U6
Antoni Llopis Lorente from @IDM_UPV_UV - @CIBER-BBN talking on "Gated silica #nanoparticles for controlled release"




























